Home > Boards > Canadian > Medical - Healthcare >

GeneNews Ltd. (TSX:GEN)

TSX:GEN RSS Feed
Add TSX:GEN Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 2/10/2018 7:07:34 PM - Followers: 1 - Board type: Free - Posts Today: 0

"GeneNews, an innovator in the liquid biopsy space, is committed to becoming a leader in advanced diagnostics and personalized medicine, serving as a strong commercialization outlet for early detection of cancer and other chronic diseases. Our mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health out-comes through the early diagnosis of disease. Our Richmond, Virginia-based Innovative Diagnostic Laboratory clinical reference lab specializes in traditional and advanced clinical evidence-based blood testing that helps find, understand, and address cancer risk in patient populations. Currently, IDL offers risk assessment blood tests for four prevalent cancer types - colon, lung, prostate and breast. GeneNews' common shares trade on the Toronto Stock Exchange under the symbol 'GEN'. More information on GeneNews and IDL can be found at www.GeneNews.com and www.myinnovativelab.com, respectively."
TSX:GEN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TSX:GEN News: Genmab Announces IFM, HOVON and Janssen Achieve Positive Topline Results in Second Part of Phase 3 CASSIOPEIA Study of Daratu... 10/21/2020 04:48:29 PM
TSX:GEN News: LTC ACO Receives Positive Reconciliation and Settlement Under the Medicare Shared Savings Program (MSSP) 10/13/2020 04:02:52 PM
TSX:GEN News: Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2020 10/13/2020 06:41:56 AM
TSX:GEN News: Genmab Commences Binding Arbitration of Two Matters Under License Agreement with Janssen 09/22/2020 05:04:08 PM
TSX:GEN News: Genmab and Seattle Genetics Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervica... 09/21/2020 10:20:00 AM
PostSubject
#13   Company didn't close the deal as anticipated. finesand 02/10/18 07:07:34 PM
#12   Status of Company and this board @ ihub finesand 02/04/18 09:42:13 PM
#11   Rory Riggs Total: C$0.55 - C$0.62 Average finesand 02/04/18 09:35:25 PM
#10   2nd day tape showing 95% buys, slapping the finesand 09/07/17 07:39:04 PM
#9   Warrants Done & Financing 200% Premium 10c -> 30c finesand 09/06/17 08:09:30 PM
#8   A sign of life in the last 3 finesand 07/04/17 06:38:20 PM
#7   copied from stockhouse: finesand 05/15/17 04:36:44 AM
#6   reversal not confirmed yet, quite boring trading days. finesand 04/28/17 11:04:00 PM
#5   support re-tested, reversal candle, finesand 04/27/17 10:38:56 AM
#4   Thank You, E*TRADE doesn't recognize GEN as GeneNews TimBo9 04/25/17 10:18:11 PM
#3   TSX:GEN, aka GEN on Toronto Stock Exchange as finesand 04/25/17 09:27:28 PM
#2   What is the trade symbol for this stock, TimBo9 04/25/17 09:00:51 PM
#1   Welcome to the GeneNews board. finesand 04/25/17 04:45:12 PM
PostSubject
Consent Preferences